Leprosy in an Adopted Woman Diagnosed by Molecular Tools: A Case Report from a Non-Endemic Area
-
Published:2023-01-20
Issue:2
Volume:12
Page:165
-
ISSN:2076-0817
-
Container-title:Pathogens
-
language:en
-
Short-container-title:Pathogens
Author:
Beltrame Anna, Fargnoli Maria ConcettaORCID, Avanzi Charlotte, Sollima Laura, Pomari ElenaORCID, Mori Antonio, Longoni Silvia StefaniaORCID, Moro LuciaORCID, Orza Pierantonio, Jackson Mary, Perandin FrancescaORCID
Abstract
Coupled with its rarity in non-endemic areas, the clinical heterogeneity of leprosy makes diagnosis very challenging. We report a diagnosis of multibacillary leprosy in a 22-year-old Indian woman, adopted at the age of 10 and living in Italy. The patient presented with painful skin lesions on the face, trunk, and lower and upper extremities, associated with dysesthesia and a motor deficit in her left leg following corticosteroid therapy interruption. Histopathology results from the skin lesions suggested leprosy, but no acid-fast bacilli were identified. Molecular biology in a center specializing in tropical diseases confirmed the diagnosis, allowing prompt and adequate treatment. Genotype analysis allowed the identification of a genotype 1D of M. leprae, facilitating the epidemiological investigation of the plausible infection origin. No resistances to rifampicin, dapsone, or ofloxacin were detected. Leprosy will continue to exist in high-income nations, and the incidence may rise over time due to increasing migration and globalization. CARE guidelines were followed.
Funder
Italian Ministry of Health “Fondi Ricerca Corrente – L3P1” Fondation Raoul Follereau New York Community Trust for Research European Union’s Horizon 2020 Research and Innovation Program
Subject
Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,Molecular Biology,Immunology and Allergy
Reference44 articles.
1. Leprosy now: Epidemiology, progress, challenges, and research gaps;Rodrigues;Lancet Infect Dis.,2011 2. Mycobacterium lepromatosis as a Second Agent of Hansen’s Disease;Deps;Front. Microbiol.,2021 3. World Health Organization (2022, October 01). Towards Zero Leprosy. Global Leprosy (Hansen’s Disease) Strategy 2021–2030. Available online: https://www.who.int/publications/i/item/9789290228509. 4. World Health Organization (2022, October 01). Global Leprosy (Hansen Disease) Update, 2020: Impact of COVID-19 on Global Leprosy Control. Available online: https://www.who.int/wer. 5. Beltrame, A., Barabino, G., Wei, Y., Clapasson, A., Orza, P., Perandin, F., Piubelli, C., Monteiro, G.B., Longoni, S.S., and Rodari, P. (2020). Leprosy in Refugees and Migrants in Italy and a Literature Review of Cases Reported in Europe between 2009 and 2018. Microorganisms, 8.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A case of leprosy in an immunocompromised traveller;Journal of Travel Medicine;2024-04-11 2. Dapsone/prednisone;Reactions Weekly;2023-03-18
|
|